GDF Drugs, Diagnostics and other TB supplies

First-line anti-TB drugs, TB diagnostics equipment and other products currently supplied by the Global Drug Facility. To view a product click on the hyperlink of that product. To view a product click on the hyperlink of that product.

GDF Product Catalogue

2nd Line Drugs	The recommended anti-TB drugs for treating patients with multidrug-resistant TB (MDR-TB) according to WHO guidelines.
Diagnostics Equipment	Diagnostic materials for use in laboratories.
1st Line Fixed Dose Combinations	Advances in the field of pharmacology have made it possible to develop quality combinations of up to four anti-TB drugs. In a single tablet, we are now able to deliver the two, three or four essential first-line drugs in the proper dosages, thus guaranteeing easy adoption of the WHO recommended regimens.
1st Line Injectibles	Additional supplies required to deliver first-line treatment for tuberculosis.
1st Line Paediatric Drugs	The essential first-line drugs required to treat paediatric patients according to the WHO recommended regimens.*
Patient Kits	GDF has 2 types of patient Kits, one for Category I or III patients and one for Category II patients, which contain the full treatment for one patient of either category.
1st Line Single Formulations	The essential first-line drugs required to treat patients according to the WHO recommended regimens.

1st Line Fixed Dose Combinations

1st Line Injectibles

1st Line Paediatric Drugs

1st Line Single Formulations

2nd Line Drugs

Diagnostics Equipment

Patient Kits

Additional Notes

Prices
These are the minimum prices GDF can currently offer. All prices are EXW supplier's plant.

Please note that in case of production capacity constraints, conflicting default lead times in relation to the required delivery date of a particular order or similar circumstances, prices for some products may be higher. For budgeting purposes, when two prices are given for a product, we would advise to apply the higher one. For assistance in estimating the costs of an order or to confirm the price of a product, please contact GDF (gdf@who.int).

Other costs
1st Line Drugs, Paediatrics and Diagnostics - Costs for pre-shipment inspection, transport (air freight or sea freight) and insurance, are not included in the product prices listed above. Please note that the respective share of these supply-related costs (notably air freight costs) in relation to the overall product costs can be elevated due to:

• Volume-to-value ratio: high-volume products with low commercial value, such as Sputum kits or Streptomycin, can attract relatively high freight costs;
• Accessibility: orders for destinations that are not serviced regularly or directly by carriers can attract increased freight costs;
• Dangerous goods status: certain products, mainly diagnostic consumables kits, are considered by many freight companies and country authorities to be dangerous goods and as such attract a surcharge;
• Order size: some freight types have minimum charges, such as per 40' container (sea freight), and if the volume of the order is less than the volume of the container, it will still be subject to minimum charge for the entire container

• The 1st line paediatric products indicated are those available at this time. However, as other WHO recommended paediatric products - i.e. Ethambutol 100mg - and formulations - e.g. child-friendly/dispersible - become available, these will be added to the GDF catalogue.
• Only projects and programs approved by the Green Light Committee can access 2nd line anti-TB drugs through GDF.
• Price option A for Capreomycin is the price offered for this product by GDF. Option B reflects a concessional price offered by Eli Lilly and Company (http://www.lilly.com/) for a limited quota of units per year.

GDF offers a selective range of high-quality anti-TB drugs

Conform to WHO recommended TB treatment guidelines

The GDF products enable the physician to treat a patient according to the latest WHO treatment guidelines.

Conform to the WHO Essential Drugs List

All GDF products are on the WHO essential drugs list, which facilitates registration and importation (with the exception of R150 mg/H75 mg/E275 mg.)

FDC formulations

The use of Fixed Dose Combination (FDC) tablets greatly contributes to rational drug use and assists in effective DOTS implementation and expansion.

FDC tablets reduce the number of tablets a patient needs to take, while avoiding mono-therapy and thereby reducing the risks of developing Multidrug-Resistant TB (MDR-TB).

Pre-qualified Products

Click here to access the Quality Assurance page.

Shelf life

GDF guarantees 3/4 remaining shelf-life of all products on arrival at the port of entry.

Pre-shipment inspection

Pre-shipment inspection of every order by an international agency, independent of the manufacturer, are conducted on packing, labelling, content and shelf life.

Quality control

Samples of all batches to be supplied are tested by an independent laboratory for compliance with the relevant pharmacopoeia.

Specially designed quality containers for loose tablets

• 1000 loose tablets in specially designed square containers of High Density Polyethylene (HDPE)
• Aluminium seal under lid
• Every container packed in individual shrink foil for full protection against humidity and easy stocktaking: “shrink foil intact = contents complete”
• One container with 1000 4FDC or 2FDC tablets will treat about 10 average patients
• Product information inserts in 6 UN languages

Specially designed blisters

GDF blisters comprise sheets of 7 rows of 4 tablets: one blister sheet contains treatment for one week for one patient of 55 - 70 kg, easily adjustable to patients of other weight bands.

Competitive prices

GDF prices are competitive, due to bulk procurement, competitive bidding, prompt payment policies and standardization of products (Refer to Management Sciences for Health: International Drug Price Indicator Guide for comparison of GDF prices with other global market prices: http://erc.msh.org/dmpguide )